N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): a new tool to probe CNS receptor function.
Meller
E
E
Department of Psychiatry, New York University School of Medicine, NY 10016.
Goldstein
M
M
Friedhoff
A J
AJ
Schweitzer
J W
JW
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D002395:Catecholamines / Q000378:metabolism; D002490:Central Nervous System / Q000187:drug effects / Q000502:physiology*; D011804:Quinolines / Q000494:pharmacology*; D051381:Rats; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects / Q000502:physiology*; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology*
D000317:Adrenergic alpha-Antagonists; D002395:Catecholamines; D011804:Quinolines; D011942:Receptors, Adrenergic, alpha; D011954:Receptors, Dopamine; C000470:EEDQ